Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-Current Assets (2023 - 2025)

Upstream Bio (UPB) has 3 years of Non-Current Assets data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 59.87% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $9.4 million, changed N/A, while the annual FY2024 figure was $2.6 million, 1166.83% up from the prior year.
  • Non-Current Assets reached $2.2 million in Q3 2025 per UPB's latest filing, down from $2.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $5.4 million in Q3 2024 and bottomed at $202000.0 in Q4 2023.
  • Average Non-Current Assets over 3 years is $2.5 million, with a median of $2.3 million recorded in 2025.
  • Peak YoY movement for Non-Current Assets: skyrocketed 1166.83% in 2024, then plummeted 59.87% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $202000.0 in 2023, then surged by 1166.83% to $2.6 million in 2024, then fell by 14.89% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $2.2 million in Q3 2025, $2.2 million in Q2 2025, and $2.4 million in Q1 2025.